Fertility preservation decisions among newly diagnosed oncology patients: A single-center experience

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 39, Issue 2, 2016, Pages 154-159

  Nurudeen, Sahadat K ^a   Douglas, Nataki C ^a   Mahany, Erica L ^a   Sauer, Mark V ^a   Choi, Janet M ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

Embryo cryopreservation; Fertility preservation; Oncofertility; Oocyte cryopreservation

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LETROZOLE; MUELLERIAN INHIBITING FACTOR; RECOMBINANT FOLLITROPIN;

ARTICLE; BODY MASS; BRAIN CANCER; BREAST CANCER; CANCER PATIENT; CANCER THERAPY; CRYOPRESERVATION; FEMALE; FERTILITY PRESERVATION; FERTILIZATION; HEMATOLOGIC MALIGNANCY; HUMAN; LUTEAL PHASE; MAJOR CLINICAL STUDY; MARRIED WOMAN; OOCYTE MATURATION; OVARY CANCER; OVARY HYPERSTIMULATION; RETROSPECTIVE STUDY; SARCOMA; SPINE CANCER; THYROID CANCER; UTERINE CERVIX CANCER; UTERUS CANCER; ADULT; COHORT ANALYSIS; INFERTILITY THERAPY; NEOPLASM; OVULATION INDUCTION; PROCEDURES; YOUNG ADULT;

ADULT; COHORT STUDIES; CRYOPRESERVATION; FEMALE; FERTILITY PRESERVATION; HUMANS; NEOPLASMS; OVULATION INDUCTION; REPRODUCTIVE TECHNIQUES, ASSISTED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84961918708     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0000000000000031     Document Type: Article

References (32)

1. Howlader NNA, Krapcho M, Neyman N, et al. SEER Cancer Statistics Review, 1975-2008. 2010. Available at: http://seer.cancer. gov/csr/1975-2008/. Accessed January 17, 2013.
2. Friedler S, Koc O, Gidoni Y, et al. Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis. Fertil Steril. 2012;97:125-133.
3. Huober-Zeeb C, Lawrenz B, Popovici RM, et al. Improving fertility preservation in cancer: ovarian tissue cryobanking followed by ovarian stimulation can be efficiently combined. Fertil Steril. 2011;95:342-344.
4. Kim SS. Fertility preservation in female cancer patients: current developments and future directions. Fertil Steril. 2006;85:1-11.
5. Lawrenz B, Jauckus J, Kupka MS, et al. Fertility preservation in >1000 patients: patient's characteristics, spectrum, efficacy and risks of applied preservation techniques. Arch Gynecol Obstet. 2011;283:651-656.
6. Johnson LNC, Dillon KE, Sammel MD, et al. Response to ovarian stimulation in patients facing gonadotoxic therapy. Reprod Biomed Online. 2013;26:337-344.
7. Schover LR. Patient attitudes toward fertility preservation. Pediatr Blood Cancer. 2009;53:281-284.
8. Browne H, Nurudeen S, Armstrong A, et al. Ethical and psychological considerations in fertility preservation counseling. Cancer J. 2008;14:340-342.
9. Canada AL, Schover LR. The psychosocial impact of interrupted childbearing in long-term female cancer survivors. Psychooncol-ogy. 2012;21:134-143.
10. The Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in patients facing gonadotoxic therapy. Fertil Steril. 2013;100:1224-1231.
11. Loren AW, Mangu PB, Beck LN, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31:2500-2511.
12. Forman EJ, Anders CK, Behera MA. A nationwide survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients. Fertil Steril. 2010;94: 1652-1656.
13. Schover LR, Brey K, Lichtin A, et al. Oncologists' attitudes and practices regarding banking sperm before cancer treatment. J Clin Oncol. 2002;20:1890-1897.
14. Quinn GP, Vadaparampil ST, Lee JH, et al. Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol. 2009;27:5952-5957.
15. Agarwal SK, Chang RJ. Fertility management for women with cancer. Cancer Treat Res. 2007;138:15-27.
16. Maltaris T, Seufert R, Fischl F, et al. The effect of cancer treatment on female fertility and strategies for preserving fertility. Eur J Obstet Gynecol Reprod Biol. 2007;130:148-155.
17. Roberts JE, Oktay K. Fertility preservation: a comprehensive approach to the young woman with cancer. J Natl Cancer Inst Monogr. 2005;34:57-59.
18. Oktay K, Cil AP, Bang H. Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril. 2006;86:70-80.
19. Lawrenz B, Jauckus J, Kupka M, et al. Efficacy and safety of ovarian stimulation before chemotherapy in 205 cases. Fertil Steril. 2010;94:2871-2873.
20. Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonado-tropins in patients with breast cancer: a prospective controlled study. J Clin Oncol. 2008;26:2630-2635.
21. Oktay K, Hourvitz A, Sahin G, et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab. 2006;91:3885-3890.
22. Robertson AD, Missmer SA, Ginsburg ES. Embryo yield after in vitro fertilization in women undergoing embryo banking for fertility preservation before chemotherapy. Fertil Steril. 2011; 95:588-591.
23. Das M, Shehata F, Moria A, et al. Ovarian reserve, response to gonadotropins, and oocyte maturity in women with malignancy. Fertil Steril. 2011;96:122-125.
24. Domingo J, Guillen V, Ayllon Y, et al. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment. Fertil Steril. 2012; 97:930-934.
25. Stoop DMN, Jansen E, Platteau P, et al. Clinical validation of a closed vitrification system in an oocyte-donation programme. Reprod Biomed Online. 2012;24:180-185.
26. Fabbri R. Human oocyte cryopreservation-new perspectives regarding oocyte survival. Hum Reprod. 2001;16:411-416.
27. Wang JG, Douglas NC, Nakhuda GS, et al. The association between anti-Mullerian hormone and IVF pregnancy outcomes is influenced by age. Reprod Biomed Online. 2010;21: 757-761.
28. Cooley A, Matthews L, Zelivianski S, et al. Effect of infertility treatment and pregnancy-related hormones on breast cell proliferation in vitro. Hum Reprod. 2012;27:146-152.
29. Boukaidi SA, Cooley A, Hardy A, et al. Impact of infertility regimens on breast cancer cells: follicle-stimulating hormone and luteinizing hormone lack a direct effect on breast cell proliferation in vitro. Fertil Steril. 2012;97:440-444.
30. Sönmezer M, Türkçüoglu I, Coşkun U, et al. Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles. Fertil Steril. 2011;95: 2125e9-2125e11.
31. Baynosa J, Westphal LM, Madrigrano A, et al. Timing of breast cancer treatments with oocyte retrieval and embryo cryopreserva-tion. J Am Coll Surg. 2009;209:603-607.
32. Oktay K, Turkcuoglu I, Rodriguez-Wallberg KA. GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation. Reprod Biomed Online. 2010;20:783-788.